RRH, URMC to initiate clinical trial on a new COVID-19 vaccine
Category: #health  By Pankaj Singh  Date: 2020-05-06
  • share
  • Twitter
  • Facebook
  • LinkedIn

RRH, URMC to initiate clinical trial on a new COVID-19 vaccine

Amidst the ongoing pandemic, several medical institutes and pharma companies are diligently working on developing an antidote for the novel coronavirus. American multinational pharma company, Pfizer and its German business partner BioNTech recently made a promising development towards this initiative when they announced their plans to initiate a clinical trial for a new Covid-19 vaccine.

Reportedly, both the companies have named the City of Rochester as one of its four cities to conduct the trial. Similarly, Rochester Regional Hospital (RRH) and the University of Rochester are teaming up to combat against the COVID-19 epidemic by testing a new vaccine called "Messenger RNA Vaccine."

The study is anticipated to involve 90 people from Rochester, aged between 18 to 85. Over the course of time, each individual would receive the Messenger RNA Vaccine, a drug that has previously been used in influenza and cancer clinical trials.

Speaking on the development, Dr. Edward Walsh from Rochester Regional Hospital, said that this trial would be considered as phase one and would be proceeding forward quickly, passing through the multiple stages within the phase one trials. These trials would last throughout the spring and could potentially span into the mid-portion of the summer.

Messenger RNA comes as a natural substance that is present in human cells acting as a deactivating mechanism. It would mitigate the bad cells in such a way that there is a limited risk of toxicity and side effects. Besides, the vaccine has enough "spike proteins" to generate antibodies, added Walsh.

As per Dr. Ann Falsey from University of Rochester Medical Center, the university feels delighted to be at the forefront of this drug development as it becomes one of the four centers to initiate this trial. The university sees people reaching out to them to offer help and this trial comes as a vital way for people to offer help.

Source Credit: https://www.whec.com/coronavirus/urmc-rrh-collaborating-on-new-clinical-trial-for-covid-19-vaccine/5720404/?cat=565

 



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

Poxel announces preclinical outcomes on PXL770 for NASH Combinations
Poxel announces preclinical outcomes on PXL770 for NASH Combinations
By Pankaj Singh

Poxel SA, the France-based dynamic biopharmaceutical firm developing advanced drugs for metabolic diseases, has reportedly announced the preclinical outcomes for PXL770, the main molecule in its AMPK (adenosine monopho...

Astellas Pharma obtains complete approval from EMA for Roxadustat
Astellas Pharma obtains complete approval from EMA for Roxadustat
By Pankaj Singh

Japanese pharmaceutical multinational major Astellas Pharma Inc., has announced the approval of its marketing authorization application for anti-anemic drug Roxadustat from the European Medicines Agency. The announceme...

J.C Penney announces plans to reopen 153 stores amid a pandemic
J.C Penney announces plans to reopen 153 stores amid a pandemic
By Pankaj Singh

While American department store chain J.C. Penney Company, Inc., may have got extra time with Chapter 11 bankruptcy filing, a countdown is still looming on the company’s scheduled exit from bankruptcy in November...